Zacks Company Profile for Hims & Hers Health, Inc. (HIMS : NYSE) |
|
|
|
Company Description |
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Number of Employees: 1,637 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $55.50 |
Daily Weekly Monthly
 |
20 Day Moving Average: 23,898,556 shares |
Shares Outstanding: 226.02 (millions) |
Market Capitalization: $12,544.11 (millions) |
Beta: 2.14 |
52 Week High: $72.98 |
52 Week Low: $15.73 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
17.76% |
15.69% |
12 Week |
-9.12% |
-17.45% |
Year To Date |
129.53% |
91.12% |
|
|
|
|
|
Address & Contact Information |
Street Address |
Phone / Fax |
Email Address |
Web URL |
2269 CHESTNUT STREET SUITE 523 - SAN FRANCISCO,CA 94123 USA |
ph: 415-851-0195 fax: - |
investors@forhims.com |
http://www.hims.com |
|
|
|
General Corporate Information |
Officers
Andrew Dudum - Chief Executive Officer and Director
Oluyemi Okupe - Chief Financial Officer
Irene Becklund - Senior Vice President; Controller
Deborah Autor - Director
Patrick H. Carroll - Director
|
|
Peer Information
Hims & Hers Health, Inc. (HLIS)
Hims & Hers Health, Inc. (AZTA)
Hims & Hers Health, Inc. (APYI)
Hims & Hers Health, Inc. (RNVA)
Hims & Hers Health, Inc. (HMSY)
Hims & Hers Health, Inc. (LRSI)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 433000106
SIC: 8011
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/03/25
|
|
Share - Related Items
Shares Outstanding: 226.02
Most Recent Split Date: (:1)
Beta: 2.14
Market Capitalization: $12,544.11 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $0.09 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $0.60 |
Payout Ratio: 0.00 |
Number of Estimates in the Fiscal Year Consensus: 6.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: 24.75% |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 11/03/25 |
|
|
|
|